7-dehydrocholesterol reductase
Zuletzt aktualisiert 18. Aug 2020
Erfüllt die redaktionelle Richtlinien
- HerunterladenHerunterladen
- Teilen
- Language
- Diskussion
- Ask Patient
- Audio-Version
- Zu bevorzugten Quellen bei Google hinzufügen
Der DHCR7 gene provides instructions for making an enzyme called 7-dehydrocholesterol reductase. This enzyme is responsible for the final step in cholesterol production in many types of cells. Specifically, 7-dehydrocholesterol reductase converts a molecule called 7-dehydrocholesterol to cholesterol.
Normal function
Der DHCR7 gene provides instructions for making an enzyme called 7-dehydrocholesterol reductase. This enzyme is responsible for the final step in cholesterol production in many types of cells. Specifically, 7-dehydrocholesterol reductase converts a molecule called 7-dehydrocholesterol to cholesterol.
Cholesterol is a waxy, fat-like substance that is produced in the body and obtained from foods that come from animals (particularly egg yolks, meat, poultry, fish, and dairy products). It has important functions both before and after birth. Cholesterol plays a critical role in embryonic development by interacting with signaling proteins that control early development of the brain, limbs, genital tract, and other structures. It is also a structural component of cell membranes and myelin, the fatty covering that insulates nerve cells. Additionally, cholesterol is used to make certain hormones and is important for the production of acids used in digestion (bile acids).
Conditions referring to this gene or chromosome
Other names
7-DHC reductase
D7SR
delta-7-dehydrocholesterol reductase
DHCR7_HUMAN
sterol delta-7-reductase
Related patient information and medicines

Patient information leaflet
Blut im Sperma
Haematospermia means there is blood in the semen. Usually there are no other symptoms such as pain. The haematospermia itself does not need any treatment. Medicines If you have persistent haematospermia without an identified cause then a type of medicine called a 5-alpha reductase inhibitor such as finasteride Finasteride for prostate gland.

Patient information leaflet
Vergrößerte Prostata
Only a quarter to a half of men with an enlarged prostate will have symptoms. Medicines The decision to treat with medicines usually depends on how much bother the symptoms are ... There are two groups of medicines that may help: Alpha-blockers. 5-alpha reductase inhibitors. Medicines do not cure the problem, nor do they usually make symptoms go.

Patient information leaflet
Prostataprobleme
This leaflet will... There are various treatments for the symptoms of BPH, including drugs such as alfuzosin/doxazosin (alpha-blockers), dutasteride/finasteride (5-alpha reductase inhibitors), oxybutinin/tolterodine/fesoterodine/darifenacin/solifenacin/trospium (antimuscarinics), mirabegron (for overactive bladder) and desmopressin (for frequent.

Patient information leaflet
Impfung gegen Grippe
Getting the flu vaccine is a safe and effective way to protect against becoming seriously ill with flu.

Patient information leaflet
Kann ich Ginkgo biloba und Aspirin zusammen einnehmen?
This might show up as easy bruising, nosebleeds, bleeding gums, or in more serious cases, internal bleeding. Why this happens Both substances affect how your blood clots, but in different ways. Aspirin is an antiplatelet medicine that stops blood cells (platelets) from sticking together. Ginkgo biloba also has blood-thinning properties. When used.

Patient information leaflet
Subdurales Hämatom
A subdural haematoma is a collection of clotting blood that forms in the subdural space.
Weiterführende Lektüre und Referenzen
- 7-dehydrocholesterol reductase; MedlinePlus, National Library of Medicine.
- Bianconi SE, Cross JL, Wassif CA, Porter FD. Pathogenesis, Epidemiology, Diagnosis and Clinical Aspects of Smith-Lemli-Opitz Syndrome. Expert Opin Orphan Drugs. 2015 Mar;3(3):267-280. doi: 10.1517/21678707.2015.1014472.
- Correa-Cerro LS, Porter FD. 3beta-hydroxysterol Delta7-reductase and the Smith-Lemli-Opitz syndrome. Mol Genet Metab. 2005 Feb;84(2):112-26. doi: 10.1016/j.ymgme.2004.09.017. Epub 2004 Dec 19.
- Jira PE, Waterham HR, Wanders RJ, Smeitink JA, Sengers RC, Wevers RA. Smith-Lemli-Opitz syndrome and the DHCR7 gene. Ann Hum Genet. 2003 May;67(Pt 3):269-80. doi: 10.1046/j.1469-1809.2003.00034.x.
- Nowaczyk MJ, Martin-Garcia D, Aquino-Perna A, Rodriguez-Vazquez M, McCaughey D, Eng B, Nakamura LM, Waye JS. Founder effect for the T93M DHCR7 mutation in Smith-Lemli-Opitz syndrome. Am J Med Genet A. 2004 Mar 1;125A(2):173-6. doi: 10.1002/ajmg.a.20676.
- Nowaczyk MJ, Waye JS. The Smith-Lemli-Opitz syndrome: a novel metabolic way of understanding developmental biology, embryogenesis, and dysmorphology. Clin Genet. 2001 Jun;59(6):375-86. doi: 10.1034/j.1399-0004.2001.590601.x.
- Porter FD. RSH/Smith-Lemli-Opitz syndrome: a multiple congenital anomaly/mental retardation syndrome due to an inborn error of cholesterol biosynthesis. Mol Genet Metab. 2000 Sep-Oct;71(1-2):163-74. doi: 10.1006/mgme.2000.3069.
- Tulenko TN, Boeze-Battaglia K, Mason RP, Tint GS, Steiner RD, Connor WE, Labelle EF. A membrane defect in the pathogenesis of the Smith-Lemli-Opitz syndrome. J Lipid Res. 2006 Jan;47(1):134-43. doi: 10.1194/jlr.M500306-JLR200. Epub 2005 Oct 28.
- Waterham HR, Hennekam RC. Mutational spectrum of Smith-Lemli-Opitz syndrome. Am J Med Genet C Semin Med Genet. 2012 Nov 15;160C(4):263-84. doi: 10.1002/ajmg.c.31346. Epub 2012 Oct 5.
- Waye JS, Krakowiak PA, Wassif CA, Sterner AL, Eng B, Nakamura LM, Nowaczyk MJ, Porter FD. Identification of nine novel DHCR7 missense mutations in patients with Smith-Lemli-Opitz syndrome (SLOS). Hum Mutat. 2005 Jul;26(1):59. doi: 10.1002/humu.9346.
- Yu H, Patel SB. Recent insights into the Smith-Lemli-Opitz syndrome. Clin Genet. 2005 Nov;68(5):383-91. doi: 10.1111/j.1399-0004.2005.00515.x.
Artikelverlauf
Artikel auch verfügbar in Englisch, Deutsch, Spanisch, Französisch, Italienisch, Portugiesisch, Hindi, Hebräisch, Arabisch, und Schwedisch.
18. Aug 2020 | Neueste Version
1 Jul 2007 | Ursprünglich veröffentlicht
Teilen Sie Ihre Gedanken oder Erfahrungen mit anderen in unserem Patientengemeinschaften.
Abonnieren Sie den Patienten-Newsletter
Ihre wöchentliche Dosis klarer, vertrauenswürdiger Gesundheitsberatung - geschrieben, um Ihnen zu helfen, sich informiert, selbstbewusst und in Kontrolle zu fühlen.
Durch das Abonnieren akzeptieren Sie unsere Datenschutzrichtlinie. Sie können sich jederzeit abmelden. Wir verkaufen Ihre Daten niemals.

